Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
  • Page of 1
Wang K, Liu YI, Li J, Wang B, Bishop R, White C, DAS A, Levine AD, Ho L, Levine BL, Fesnak AD. A multiscale simulation framework for the manufacturing facility and supply chain of autologous cell therapies. Cytotherapy. 2019 Aug 21;. doi: 10.1016/j.jcyt.2019.07.002. [Epub ahead of print] PubMed PMID: 31445816.
Fesnak A. The Challenge of Variability in Chimeric Antigen Receptor T Cell Manufacturing. Regenerative Engineering and Translational Medicine. 2019 August; doi: 10.1007/s40883-019-00124-3.
Ohayon Y, Corl C, Leskowitz R, Malykhin A, Arostegui S, Hennesy N, Ngo S, Levine B, Siegel D, Fesnak A, Davis M. Robust automated cell counter and viability measurement for engineered T cell product release. Cytotherapy. 2018 May; 20(5):S69-. doi: 10.1016/j.jcyt.2018.02.193.
Fesnak AD, Hanley PJ, Levine BL. Considerations in T Cell Therapy Product Development for B Cell Leukemia and Lymphoma Immunotherapy. Curr Hematol Malig Rep. 2017 Aug;12(4):335-343. doi: 10.1007/s11899-017-0395-9. Review. PubMed PMID: 28762038; PubMed Central PMCID: PMC5693739.
Davis MM, Fesnak AD, Leskowitz RM, Mckee JS, Ohayon Y, Corl CM, Malykhin A, Fraietta JA, Melenhorst JJ, June CH, Schuster S. Predictors of manufacturing (MFG) success for chimeric antigen receptor (CAR) T cells in Non-Hodgkin Lymphoma (NHL). Cytotherapy. 2017 May; 19(5):S118-9.
Levine BL, Fesnak AD, Riviere I. Showcasing Clinical Development and Production of Cellular Therapies. Mol Ther. 2017 Apr 5;25(4):827-828. doi: 10.1016/j.ymthe.2017.03.007. Epub 2017 Mar 22. PubMed PMID: 28341560; PubMed Central PMCID: PMC5383642.
Fesnak A, O'Doherty U. Clinical Development and Manufacture of Chimeric Antigen Receptor T cells and the Role of Leukapheresis. European Oncology & Haematology. 2017; 13(1):28-34. doi: 10.17925/EOH.2017.13.01.28.
Fesnak AD, June CH, Levine BL. Engineered T cells: the promise and challenges of cancer immunotherapy. Nat Rev Cancer. 2016 Aug 23;16(9):566-81. doi: 10.1038/nrc.2016.97. Review. PubMed PMID: 27550819; PubMed Central PMCID: PMC5543811.
Fesnak A, Lin C, Siegel DL, Maus MV. CAR-T Cell Therapies From the Transfusion Medicine Perspective. Transfus Med Rev. 2016 Jul;30(3):139-45. doi: 10.1016/j.tmrv.2016.03.001. Epub 2016 Mar 28. Review. PubMed PMID: 27067907; PubMed Central PMCID: PMC4914456.
Levine B, Maude S, Zheng Z, Shaw P, Ambrose D, Aplenc R, Barker C, Barrett D, Brogdon J, Callahan C, Chen F, Chew A, Suhoski Davis M, Fesnak A, Finklestein J, Frey N, Lacey S, Lamontagne A, Lewitt L, Loew A, Marcucci K, Melenhorst J, Motley L, Mudambi M, Nazimuddin F, O'Rourke M, Porter D, Rheingold S, Scholler J, Tayor C, White C, Wood P, Young R, Teachey D, June C, Grupp S. Durable Remissions with Control of Cytokine Release Syndrome (CRS) Using T Cells Expressing CD19 Targeted Chimeric Antigen Receptor (CAR) CTL019 to Treat Relapsed/Refractory (R/R) Acute Lymphoid Leukemia (ALL). Cytotherapy. 2016 June; 18(6):S14-S15. doi: 10.1016/j.jcyt.2016.03.039.
Karimi MA, Bryson JL, Richman LP, Fesnak AD, Leichner TM, Satake A, Vonderheide RH, Raulet DH, Reshef R, Kambayashi T. NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT. Blood. 2015 Jun 4;125(23):3655-63. doi: 10.1182/blood-2015-02-629006. Epub 2015 Mar 18. PubMed PMID: 25788701; PubMed Central PMCID: PMC4458804.
Fesnak A. Conceptualizing Physician Professionalism. JAMA. 2011 April; 305(14):1411-. doi: 10.1001/jama.2011.425.
Vinocur JM, Fesnak AD, Liu Y, Charan D, Prak ET. Violations of the 12/23 rule at the mouse immunoglobulin kappa locus, including V kappa-V kappa rearrangement. Mol Immunol. 2009 Jul;46(11-12):2183-9. doi: 10.1016/j.molimm.2009.04.021. Epub 2009 May 20. PubMed PMID: 19467709; PubMed Central PMCID: PMC2697664.
Kotlyar, David, Perez, Elena, Blonski, Wojciech, Brensinger, Colleen, Fesnak, Andrew, Lin, Ming, Mendizabal, Manuel, Lichtenstein, Gary. A Meta-analysis of GI complications in Common Variable Immune Deficiency (CVID). American Journal of Gastroenterology. 2009; 104:S437.
Kotlyar, David, Perez, Elena, Blonski, Wojciech, Brensinger, Colleen, Fesnak, Andrew, Lin, Ming, Mendizabal, Manuel, Lichtenstein, Gary. A Meta-analysis of Hepatic Complications in Common Variable Immune Deficiency (CVID). American Journal of Gastroenterology. 2009; 104:S123-S124.
Fesnak, A., Mastoris, J., Ley, S., Henry, D.. Routine blood draw during chemotherapy does not cause significant iron deficiency. Blood. 2005; 106(11):8B.
What would you like to do?
  • Page of 1